Patents by Inventor Christian Rommel

Christian Rommel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
    Publication number: 20220372048
    Abstract: Chemical entities that modulate PI3 kinase activity, and chemical entities, pharmaceutical compositions, and methods of treatments of diseases and conditions associated with P13 kinase activity are described herein.
    Type: Application
    Filed: November 20, 2020
    Publication date: November 24, 2022
    Inventors: Pingda Ren, Yi Liu, Troy Edward Wilson, Katrina Chan, Christian Rommel, Liansheng Li
  • Certain chemical entities, compositions and methods
    Patent number: 11433065
    Abstract: Chemical entities that modulate PI3 kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities for treating diseases and conditions associated with P13 kinase activity are described herein.
    Type: Grant
    Filed: August 29, 2019
    Date of Patent: September 6, 2022
    Assignee: Intellikine LLC
    Inventors: Pingda Ren, Yi Liu, Troy Edward Wilson, Liansheng Li, Katrina Chan, Christian Rommel
  • CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
    Publication number: 20220265637
    Abstract: Chemical entities that modulate PI3 kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities for treating diseases and conditions associated with PI3 kinase activity are described herein.
    Type: Application
    Filed: October 19, 2021
    Publication date: August 25, 2022
    Inventors: Pingda REN, Yi LIU, Troy Edward WILSON, Liansheng LI, Katrina CHAN, Christian ROMMEL
  • CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
    Publication number: 20200222384
    Abstract: Chemical entities that modulate PI3 kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities for treating diseases and conditions associated with P13 kinase activity are described herein.
    Type: Application
    Filed: August 29, 2019
    Publication date: July 16, 2020
    Inventors: Pingda Ren, Yi Liu, Troy Edward Wilson, Liansheng Li, Katrina Chan, Christian Rommel
  • CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
    Publication number: 20190290636
    Abstract: Chemical entities that modulate PI3 kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities for treating diseases and conditions associated with PI3 kinase activity are described herein.
    Type: Application
    Filed: October 26, 2018
    Publication date: September 26, 2019
    Inventors: Pingda Ren, Yi Liu, Troy Edward Wilson, Liansheng Li, Katrina Chan, Christian Rommel
  • Container and blow mold
    Patent number: 10414085
    Abstract: The invention relates to a container (1) for receiving a liquid content, comprising a container wall (10) which surrounds a container interior (12) and comprises an opening (8). The container wall has an opening region (2) at the opening, a base region (4) arranged opposite the opening region, and a lateral region (3) which extends between the opening region and the base region, and the container wall has a dimensionally stable central region (22) in the base region and a flexible flat region (24) which encircles the central region. The container wall transitions from the central region into the flat region at an angle such that an edge (26) which encircles the central region is formed in the container wall between the central region and the flat region. The invention further relates to a blow mold (31) for producing such a container.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: September 17, 2019
    Assignee: KHS Corpoplast GmbH
    Inventors: Jens-Uwe Haubenschild, Arne Wiese, Christian Rommel
  • Cluster pack comprising containers having a reinforced wall section
    Patent number: 10399731
    Abstract: A cluster pack comprises at least two containers connected by a glued joint. One of the containers has a thickened wall region in the region of the glued joint. This region acts as a well reinforcement to reduce the risk of tearing a container during detachment from the cluster pack.
    Type: Grant
    Filed: December 22, 2015
    Date of Patent: September 3, 2019
    Assignee: KHS GmbH
    Inventors: Frank Haesendonckx, Christian Rommel
  • Combination pharmaceutical compositions and uses thereof
    Patent number: 10172858
    Abstract: The present invention provides for methods and pharmaceutical compositions for treating proliferative disorders. In one aspect, the method comprises administration of two cell-cycle suppressors having a synergistic effect. In another aspect, two cell-cycle suppressors having a synergistic effect are provided in a pharmaceutical composition.
    Type: Grant
    Filed: April 7, 2016
    Date of Patent: January 8, 2019
    Assignee: INTELLIKINE LLC
    Inventors: Yi Liu, Pingda Ren, Katayoun Jessen, Xin Guo, Christian Rommel
  • CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
    Publication number: 20180258103
    Abstract: Chemical entities that modulate PI3 kinase activity, and chemical entities, pharmaceutical compositions, and methods of treatments of diseases and conditions associated with P13 kinase activity are described herein.
    Type: Application
    Filed: October 20, 2017
    Publication date: September 13, 2018
    Inventors: Pingda Ren, Yi Liu, Troy Edward Wilson, Katrina Chan, Christian Rommel, Liansheng Li
  • CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
    Publication number: 20180098983
    Abstract: Chemical entities that modulate PI3 kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities for treating diseases and conditions associated with P13 kinase activity are described herein.
    Type: Application
    Filed: May 18, 2017
    Publication date: April 12, 2018
    Inventors: Pingda REN, Yi LIU, Troy Edward WILSON, Liansheng LI, Katrina CHAN, Christian ROMMEL
  • CONTAINER AND BLOW MOLD
    Publication number: 20180029282
    Abstract: The invention relates to a container (1) for receiving a liquid content, comprising a container wall (10) which surrounds a container interior (12) and comprises an opening (8). The container wall has an opening region (2) at the opening, a base region (4) arranged opposite the opening region, and a lateral region (3) which extends between the opening region and the base region, and the container wall has a dimensionally stable central region (22) in the base region and a flexible flat region (24) which encircles the central region. The container wall transitions from the central region into the flat region at an angle such that an edge (26) which encircles the central region is formed in the container wall between the central region and the flat region. The invention further relates to a blow mold (31) for producing such a container.
    Type: Application
    Filed: March 18, 2016
    Publication date: February 1, 2018
    Inventors: Jens-Uwe HAUBENSCHILD, Arne WIESE, Christian ROMMEL
  • CLUSTER PACK COMPRISING CONTAINERS HAVING A REINFORCED WALL SECTION
    Publication number: 20180002058
    Abstract: A cluster pack comprises at least two containers connected by a glued joint. One of the containers has a thickened wall region in the region of the glued joint. This region acts as a well reinforcement to reduce the risk of tearing a container during detachment from the cluster pack.
    Type: Application
    Filed: December 22, 2015
    Publication date: January 4, 2018
    Inventors: Frank HAESEDONCKX, Christian ROMMEL
  • Certain chemical entities, compositions and methods
    Patent number: 9822131
    Abstract: Chemical entities that modulate PI3 kinase activity, and chemical entities, pharmaceutical compositions, and methods of treatments of diseases and conditions associated with P13 kinase activity are described herein.
    Type: Grant
    Filed: March 3, 2016
    Date of Patent: November 21, 2017
    Assignee: Intellikine LLC
    Inventors: Pingda Ren, Yi Liu, Troy Edward Wilson, Katrina Chan, Christian Rommel, Liansheng Li
  • CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
    Publication number: 20170281614
    Abstract: Chemical entities that modulate PI3 kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities for treating diseases and conditions associated with PI3 kinase activity are described herein.
    Type: Application
    Filed: November 9, 2016
    Publication date: October 5, 2017
    Inventors: Pingda Ren, Yi Liu, Troy Edward Wilson, Liansheng Li, Katrina Chan, Christian Rommel
  • TREATMENT REGIMENS USING MULTIPLE PHARMACEUTICAL AGENTS
    Publication number: 20170209448
    Abstract: The present invention provides for methods and pharmaceutical compositions for treating disorders using treatment regimens involving multiple agents. In one aspect, a method of treatment is provided resulting in reduced toxicity and/or synergistic effect by administration according to a described dosing schedule.
    Type: Application
    Filed: February 7, 2017
    Publication date: July 27, 2017
    Inventors: Yi Liu, Shunyou Wang, Matthew R. Janes, Guibei Lan, Pingda Ren, Christian Rommel
  • Combination of kinase inhibitors and uses thereof
    Patent number: 9682141
    Abstract: The present invention provides for a method for treating a disease condition associated with PI3-kinase a and/or a receptor tyrosine kinase (RTK) in a subject. In another aspect, the invention provides for a method for treating a disease condition associated with PI3-kinase ? and/or an RTK in a subject. In yet another aspect, a method of inhibiting phosphorylation of Akt (S473) in a cell is set forth.
    Type: Grant
    Filed: November 12, 2012
    Date of Patent: June 20, 2017
    Assignee: Intellikine LLC
    Inventors: Katayoun Jessen, Xin Guo, Pingda Ren, Christian Rommel, Yi Liu
  • Enhanced treatment regimens using mTOR inhibitors
    Patent number: 9669032
    Abstract: The present invention provides for methods and pharmaceutical compositions comprising inhibitors of mTorC1 and/or mTorC2. In some aspects, the invention provides for treatment regimens resulting in enhanced treatment efficacy and better tolerability.
    Type: Grant
    Filed: October 15, 2015
    Date of Patent: June 6, 2017
    Assignee: Intellikine LLC
    Inventors: Yi Liu, Lynne Bui, Michael Martin, Troy Edward Wilson, Christian Rommel
  • Certain chemical entities, compositions and methods
    Patent number: 9655892
    Abstract: Chemical entities that modulate PI3 kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities for treating diseases and conditions associated with P13 kinase activity are described herein.
    Type: Grant
    Filed: November 11, 2015
    Date of Patent: May 23, 2017
    Assignee: Intellikine LLC
    Inventors: Pingda Ren, Yi Liu, Troy Edward Wilson, Liansheng Li, Katrina Chan, Christian Rommel
  • MTOR modulators and uses thereof
    Patent number: 9629843
    Abstract: The present invention provides methods and compositions for selective modulation of certain protein kinases, and especially mTor complexes. The methods and compositions are particularly useful in inhibiting mTor selectively for therapeutic applications.
    Type: Grant
    Filed: June 5, 2015
    Date of Patent: April 25, 2017
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, INTELLIKINE, INC.
    Inventors: Kevan M. Shokat, David Fruman, Pingda Ren, Troy Edward Wilson, Liansheng Li, Andrew Hsieh, Morris Feldman, Beth Apsel, Yi Liu, Christian Rommel, Katrina Chan, Davide Ruggero, David Pearce, Matthew Janes
  • Substituted Isoquinolin-1(2H)-one compounds, compositions, and methods thereof
    Patent number: 9522146
    Abstract: Chemical entities that modulate PI3 kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities for treating diseases and conditions associated with PI3 kinase activity are described herein.
    Type: Grant
    Filed: October 15, 2015
    Date of Patent: December 20, 2016
    Assignee: Intellikine LLC
    Inventors: Pingda Ren, Yi Liu, Troy Edward Wilson, Liansheng Li, Katrina Chan, Christian Rommel